Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

CABLES1 Deficiency Impairs Quiescence and Stress Responses of Hematopoietic Stem Cells in Intrinsic and Extrinsic Manners.

He L, Beghi F, Baral V, Dépond M, Zhang Y, Joulin V, Rueda BR, Gonin P, Foudi A, Wittner M, Louache F.

Stem Cell Reports. 2019 Aug 13;13(2):274-290. doi: 10.1016/j.stemcr.2019.06.002. Epub 2019 Jul 18.

2.

The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancer.

Fourcade A, Payrard C, Tissot V, Perrouin-Verbe MA, Demany N, Serey-Effeil S, Callerot P, Coquet JB, Doucet L, Deruelle C, Joulin V, Nonent M, Fournier G, Valeri A.

Scand J Urol. 2018 Jun;52(3):174-179. doi: 10.1080/21681805.2018.1438509. Epub 2018 Feb 20.

PMID:
29463177
3.

Long-term Patient-reported Clinical Outcomes and Reoperation Rate after Photovaporization with the XPS-180W GreenLight Laser.

Calves J, Thoulouzan M, Perrouin-Verbe MA, Joulin V, Valeri A, Fournier G.

Eur Urol Focus. 2019 Jul;5(4):676-680. doi: 10.1016/j.euf.2017.10.006.

PMID:
29102672
4.

[Outcomes of GreenLight XPS-180W laser photovaporization for BPH larger than 80mL].

Thoulouzan M, Perrouin-Verbe MA, Calves J, Deruelle C, Joulin V, Valeri A, Fournier G.

Prog Urol. 2017 Jun - Jul;27(8-9):489-496. doi: 10.1016/j.purol.2017.04.001. Epub 2017 May 5. French.

PMID:
28483481
5.

CXCR4/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress.

Zhang Y, Dépond M, He L, Foudi A, Kwarteng EO, Lauret E, Plo I, Desterke C, Dessen P, Fujii N, Opolon P, Herault O, Solary E, Vainchenker W, Joulin V, Louache F, Wittner M.

Sci Rep. 2016 Nov 25;6:37827. doi: 10.1038/srep37827.

6.

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.

Hirsch P, Zhang Y, Tang R, Joulin V, Boutroux H, Pronier E, Moatti H, Flandrin P, Marzac C, Bories D, Fava F, Mokrani H, Betems A, Lorre F, Favier R, Féger F, Mohty M, Douay L, Legrand O, Bilhou-Nabera C, Louache F, Delhommeau F.

Nat Commun. 2016 Aug 18;7:12475. doi: 10.1038/ncomms12475.

7.

Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization.

Driffort V, Gillet L, Bon E, Marionneau-Lambot S, Oullier T, Joulin V, Collin C, Pagès JC, Jourdan ML, Chevalier S, Bougnoux P, Le Guennec JY, Besson P, Roger S.

Mol Cancer. 2014 Dec 11;13:264. doi: 10.1186/1476-4598-13-264.

8.

[Comparison of the morbidity between limited and extended pelvic lymphadenectomy during laparoscopic radical prostatectomy].

Rousseau B, Doucet L, Perrouin Verbe MA, Papin G, Erauso A, Joulin V, Deruelle C, Valeri A, Fournier G.

Prog Urol. 2014 Feb;24(2):114-20. doi: 10.1016/j.purol.2013.07.018. Epub 2013 Nov 5. French.

PMID:
24485081
9.

Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases.

Chantôme A, Potier-Cartereau M, Clarysse L, Fromont G, Marionneau-Lambot S, Guéguinou M, Pagès JC, Collin C, Oullier T, Girault A, Arbion F, Haelters JP, Jaffrès PA, Pinault M, Besson P, Joulin V, Bougnoux P, Vandier C.

Cancer Res. 2013 Aug 1;73(15):4852-61. doi: 10.1158/0008-5472.CAN-12-4572. Epub 2013 Jun 17.

10.

[Urinary continence following laparoscopic radical prostatectomy: qualitative analysis].

Erauso A, Perrouin-Verbe MA, Papin G, Volant A, Doucet L, Joulin V, Deruelle C, Rousseau B, Valeri A, Fournier G.

Prog Urol. 2012 Nov;22(15):945-53. doi: 10.1016/j.purol.2012.07.005. Epub 2012 Sep 5. French.

PMID:
23102017
11.

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.

Zhang Y, Patel S, Abdelouahab H, Wittner M, Willekens C, Shen S, Betems A, Joulin V, Opolon P, Bawa O, Pasquier F, Ito M, Fujii N, Gonin P, Solary E, Vainchenker W, Coppo P, De Botton S, Louache F.

Cell Death Dis. 2012 Oct 4;3:e396. doi: 10.1038/cddis.2012.137.

12.

Targeting SKCa channels in cancer: potential new therapeutic approaches.

Girault A, Haelters JP, Potier-Cartereau M, Chantôme A, Jaffrés PA, Bougnoux P, Joulin V, Vandier C.

Curr Med Chem. 2012;19(5):697-713. Review.

PMID:
22204342
13.

New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis.

Girault A, Haelters JP, Potier-Cartereau M, Chantome A, Pinault M, Marionneau-Lambot S, Oullier T, Simon G, Couthon-Gourvès H, Jaffrès PA, Corbel B, Bougnoux P, Joulin V, Vandier C.

Curr Cancer Drug Targets. 2011 Nov;11(9):1111-25.

PMID:
21999627
14.

Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma.

Gardie B, Remenieras A, Kattygnarath D, Bombled J, Lefèvre S, Perrier-Trudova V, Rustin P, Barrois M, Slama A, Avril MF, Bessis D, Caron O, Caux F, Collignon P, Coupier I, Cremin C, Dollfus H, Dugast C, Escudier B, Faivre L, Field M, Gilbert-Dussardier B, Janin N, Leport Y, Leroux D, Lipsker D, Malthieu F, McGilliwray B, Maugard C, Méjean A, Mortemousque I, Plessis G, Poppe B, Pruvost-Balland C, Rooker S, Roume J, Soufir N, Steinraths M, Tan MH, Théodore C, Thomas L, Vabres P, Van Glabeke E, Meric JB, Verkarre V, Lenoir G, Joulin V, Deveaux S, Cusin V, Feunteun J, Teh BT, Bressac-de Paillerets B, Richard S; French National Cancer Institute "Inherited predisposition to kidney cancer" network.

J Med Genet. 2011 Apr;48(4):226-34. doi: 10.1136/jmg.2010.085068. Epub 2011 Mar 12. Erratum in: J Med Genet. 2011 Aug;48(8):576.

15.

The SK3/K(Ca)2.3 potassium channel is a new cellular target for edelfosine.

Potier M, Chantome A, Joulin V, Girault A, Roger S, Besson P, Jourdan ML, LeGuennec JY, Bougnoux P, Vandier C.

Br J Pharmacol. 2011 Jan;162(2):464-79. doi: 10.1111/j.1476-5381.2010.01044.x.

16.

The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk.

Chajès V, Joulin V, Clavel-Chapelon F.

Curr Opin Lipidol. 2011 Feb;22(1):6-10. doi: 10.1097/MOL.0b013e3283404552. Review.

PMID:
20935562
17.

Altered SK3/KCa2.3-mediated migration in adenomatous polyposis coli (Apc) mutated mouse colon epithelial cells.

Potier M, Tran TA, Chantome A, Girault A, Joulin V, Bougnoux P, Vandier C, Pierre F.

Biochem Biophys Res Commun. 2010 Jun 18;397(1):42-7. doi: 10.1016/j.bbrc.2010.05.046. Epub 2010 May 26.

PMID:
20519134
18.

Serum carotenoid, tocopherol and retinol concentrations and breast cancer risk in the E3N-EPIC study.

Maillard V, Kuriki K, Lefebvre B, Boutron-Ruault MC, Lenoir GM, Joulin V, Clavel-Chapelon F, Chajès V.

Int J Cancer. 2010 Sep 1;127(5):1188-96. doi: 10.1002/ijc.25138.

19.

Correlation between serum phospholipid fatty acids and dietary intakes assessed a few years earlier.

Thiébaut AC, Rotival M, Gauthier E, Lenoir GM, Boutron-Ruault MC, Joulin V, Clavel-Chapelon F, Chajès V.

Nutr Cancer. 2009;61(4):500-9. doi: 10.1080/01635580802710717.

PMID:
19838922
20.

KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility.

Chantome A, Girault A, Potier M, Collin C, Vaudin P, Pagès JC, Vandier C, Joulin V.

Exp Cell Res. 2009 Dec 10;315(20):3620-30. doi: 10.1016/j.yexcr.2009.07.021. Epub 2009 Jul 30.

PMID:
19646982
21.

MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S.

Bénard J, Raguénez G, Kauffmann A, Valent A, Ripoche H, Joulin V, Job B, Danglot G, Cantais S, Robert T, Terrier-Lacombe MJ, Chassevent A, Koscielny S, Fischer M, Berthold F, Lipinski M, Tursz T, Dessen P, Lazar V, Valteau-Couanet D.

Mol Oncol. 2008 Oct;2(3):261-71. doi: 10.1016/j.molonc.2008.07.002. Epub 2008 Jul 23.

22.

Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer.

Thiébaut AC, Chajès V, Gerber M, Boutron-Ruault MC, Joulin V, Lenoir G, Berrino F, Riboli E, Bénichou J, Clavel-Chapelon F.

Int J Cancer. 2009 Feb 15;124(4):924-31. doi: 10.1002/ijc.23980.

23.

Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study.

Chajès V, Thiébaut AC, Rotival M, Gauthier E, Maillard V, Boutron-Ruault MC, Joulin V, Lenoir GM, Clavel-Chapelon F.

Am J Epidemiol. 2008 Jun 1;167(11):1312-20. doi: 10.1093/aje/kwn069. Epub 2008 Apr 4.

24.

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, André F, Delaloge S, Tursz T, Kroemer G, Zitvogel L.

Nat Med. 2007 Sep;13(9):1050-9. Epub 2007 Aug 19.

PMID:
17704786
25.

Haplotype-based analysis of common variation in the acetyl-coA carboxylase alpha gene and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition.

Sinilnikova OM, McKay JD, Tavtigian SV, Canzian F, DeSilva D, Biessy C, Monnier S, Dossus L, Boillot C, Gioia L, Hughes DJ, Jensen MK, Overvad K, Tjonneland A, Olsen A, Clavel-Chapelon F, Chajès V, Joulin V, Linseisen J, Chang-Claude J, Boeing H, Dahm S, Trichopoulou A, Trichopoulos D, Koliva M, Khaw KT, Bingham S, Allen NE, Key T, Palli D, Panico S, Berrino F, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Lund E, Pera G, Quirós JR, Dorronsoro M, Martínez García C, Tormo MJ, Ardanaz E, Hallmans G, Lenner P, Berglund G, Manjer J, Riboli E, Lenoir GM, Kaaks R.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):409-15.

26.

Identification of SK3 channel as a new mediator of breast cancer cell migration.

Potier M, Joulin V, Roger S, Besson P, Jourdan ML, Leguennec JY, Bougnoux P, Vandier C.

Mol Cancer Ther. 2006 Nov;5(11):2946-53.

27.

Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival.

Taccoen X, Valeri A, Descotes JL, Morin V, Stindel E, Doucet L, Joulin V, Bocqueraz F, Coulange C, Rambeaud JJ, Fournier G, Mejean A; Oncology Committee of the Association Française d'Urologie.

Eur Urol. 2007 Apr;51(4):980-7. Epub 2006 Oct 25.

PMID:
17092632
28.

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Lukanova A, Rinaldi S, Dossus L, Slimani N, Lundin E, Tjønneland A, Olsen A, Overvad K, Clavel-Chapelon F, Mesrine S, Joulin V, Linseisen J, Rohrmann S, Pischon T, Boeing H, Trichopoulos D, Trichopoulou A, Benetou V, Palli D, Berrino F, Tumino R, Sacerdote C, Mattiello A, Quirós JR, Mendez MA, Sánchez MJ, Larrañaga N, Tormo MJ, Ardanaz E, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Khaw KT, Bingham S, Allen N, Key T, Jenab M, Riboli E.

J Clin Endocrinol Metab. 2007 Jan;92(1):255-63. Epub 2006 Oct 24.

PMID:
17062769
29.

Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival.

Chajès V, Cambot M, Moreau K, Lenoir GM, Joulin V.

Cancer Res. 2006 May 15;66(10):5287-94.

30.

Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences.

Lou DQ, Molina T, Bennoun M, Porteu A, Briand P, Joulin V, Vasseur-Cognet M, Cavard C.

Cancer Lett. 2005 Nov 8;229(1):107-14.

PMID:
16157222
31.

[Idiopathic acute partial renal infarction].

Joulin V, Sallusto F, Deruelle C, Taccoen X, Valeri A, Fournier G.

Prog Urol. 2005 Feb;15(1):75-7. Review. French.

PMID:
15822398
32.

Asymmetric expression of transcripts derived from the shared promoter between the divergently oriented ACACA and TADA2L genes.

Travers MT, Cambot M, Kennedy HT, Lenoir GM, Barber MC, Joulin V.

Genomics. 2005 Jan;85(1):71-84.

PMID:
15607423
33.

Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility.

Sinilnikova OM, Ginolhac SM, Magnard C, Léoné M, Anczukow O, Hughes D, Moreau K, Thompson D, Coutanson C, Hall J, Romestaing P, Gérard JP, Bonadona V, Lasset C, Goldgar DE, Joulin V, Venezia ND, Lenoir GM.

Carcinogenesis. 2004 Dec;25(12):2417-24. Epub 2004 Aug 27.

PMID:
15333468
34.

Allelic losses in localized prostate cancer: association with prognostic factors.

Fromont G, Joulin V, Chantrel-Groussard K, Vallancien G, Guillonneau B, Validire P, Latil A, Cussenot O.

J Urol. 2003 Oct;170(4 Pt 1):1394-7.

PMID:
14501776
35.

Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis.

Tralhao JG, Roudier J, Morosan S, Giannini C, Tu H, Goulenok C, Carnot F, Zavala F, Joulin V, Kremsdorf D, Bréchot C.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):6991-6.

36.

Effect of Bcl-2 expression on hepatic preneoplasia in mice.

Gillet R, Grimber G, Cavard C, Bennoun M, Mignon A, Briand P, Joulin V.

Cancer Lett. 2002 Mar 28;177(2):189-95.

PMID:
11825666
37.

Hepatic expression of SV40 small-T antigen blocks the in vivo CD95-mediated apoptosis.

Gillet R, Cavard C, Grimber G, Briand P, Joulin V.

Biochem Biophys Res Commun. 2001 Jun 8;284(2):369-76.

PMID:
11394888
38.

The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.

Gillet R, Grimber G, Bennoun M, Caron de Fromentel C, Briand P, Joulin V.

Oncogene. 2000 Jul 20;19(31):3498-507.

39.

GATA-1 is a potential repressor of anti-Müllerian hormone expression during the establishment of puberty in the mouse.

Beau C, Rauch M, Joulin V, Jégou B, Guerrier D.

Mol Reprod Dev. 2000 Jun;56(2):124-38.

PMID:
10813843
40.

LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.

Mignon A, Rouquet N, Fabre M, Martin S, Pagès JC, Dhainaut JF, Kahn A, Briand P, Joulin V.

Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1308-15.

PMID:
10194182
41.

[Apoptosis and liver diseases].

Joulin V.

C R Seances Soc Biol Fil. 1998;192(6):1077-94. Review. French.

PMID:
10101604
42.

The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice.

Bennoun M, Grimber G, Couton D, Seye A, Molina T, Briand P, Joulin V.

Oncogene. 1998 Sep 10;17(10):1253-9.

43.

Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.

Bobé P, Bonardelle D, Reynès M, Godeau F, Mahiou J, Joulin V, Kiger N.

J Immunol. 1997 Nov 1;159(9):4197-204.

PMID:
9379013
44.

[A drug for treating fulminant hepatitis?].

Mignon A, Cardoso J, Joulin V, Soubrane O.

Gastroenterol Clin Biol. 1997;21(8-9):581-3. French. No abstract available.

45.

Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes.

Rouquet N, Carlier K, Briand P, Wiels J, Joulin V.

Biochem Biophys Res Commun. 1996 Dec 4;229(1):27-35.

PMID:
8954079
46.

Detection of bcl-2 rearrangement in HIV-related follicular lymphoid hyperplasia.

Molina TJ, Devez F, Bigorgne C, Le Tourneau A, Joulin V, Audouin J, Diebold J.

Br J Haematol. 1996 Sep;94(4):705-8.

PMID:
8826897
47.

ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis.

Rouquet N, Pagès JC, Molina T, Briand P, Joulin V.

Curr Biol. 1996 Sep 1;6(9):1192-5.

48.

Glucocorticoid and progestin receptors are differently involved in the cooperation with a structural element of the mouse mammary tumor virus promoter.

Le Ricousse S, Gouilleux F, Fortin D, Joulin V, Richard-Foy H.

Proc Natl Acad Sci U S A. 1996 May 14;93(10):5072-7.

49.

Protection of hepatocytes from Fas-mediated apoptosis by a non-transforming SV40 T-antigen mutant.

Rouquet N, Allemand I, Grimber G, Molina T, Briand P, Joulin V.

Cell Death Differ. 1996 Jan;3(1):91-6.

PMID:
17180059
50.

Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.

Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V, Kahn A.

Nat Med. 1996 Jan;2(1):80-6.

PMID:
8564847

Supplemental Content

Loading ...
Support Center